Study suggests metformin improves epilepsy and reduces SEGA size
New research has shown that metformin - a common medicine used in type 2 diabetes - can improve TSC-related epilepsy and reduce the size of SEGAs (subependymal giant cell astrocytoma non-cancerous tumours). The study could have important implications for the way that TSC is